In this guide
In association with
2024 Highlights
Swiss biotech ecosystem recuperates from global financial instability
Cell and gene therapy approvals drive paradigm change in manufacturing
Will the tide turn for the wave of pharma layoffs?
AIDS 24: Prioritise at risk populations for trials, testing and treatment
Pharma readies for climate disasters amidst supply chain concerns
Amgen showcases exciting potential in the obesity space at JPM24
Experts call for clinical trial supply framework shift